메뉴 건너뛰기




Volumn 41, Issue 4, 2011, Pages 320-326

Interactions between the chemotherapeutic agent eribulin mesylate (E7389) and P-glycoprotein in CF-1 abcb1a-deficient mice and Caco-2 cells

Author keywords

Caco 2 cells; CF 1 abcb1a deficient mice; drug drug interactions; eribulin; P glycoprotein

Indexed keywords

DIGOXIN; ERIBULIN; GLYCOPROTEIN P;

EID: 79952936148     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498254.2010.542256     Document Type: Article
Times cited : (24)

References (29)
  • 1
    • 35148867503 scopus 로고    scopus 로고
    • Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1). I. Preclinical aspects
    • DOI 10.1016/j.drudis.2007.07.022, PII S1359644607003030
    • Aszalos A. (2007). Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1) I. Preclinical aspects. Drug Discov Today 12:833-837. (Pubitemid 47539963)
    • (2007) Drug Discovery Today , vol.12 , Issue.19-20 , pp. 833-837
    • Aszalos, A.1
  • 2
    • 0346728729 scopus 로고    scopus 로고
    • The ABCs of drug transport in intestine and liver: Efflux proteins limiting drug absorption and bioavailability
    • DOI 10.1016/j.ejps.2003.07.003
    • Chan LM, Lowes S, Hirst BH. (2004). The ABCs of drug transport in intestine and liver: Efflux proteins limiting drug absorption and bioavailability. Eur J Pharm Sci 21:25-51. (Pubitemid 38050202)
    • (2004) European Journal of Pharmaceutical Sciences , vol.21 , Issue.1 , pp. 25-51
    • Chan, L.M.S.1    Lowes, S.2    Hirst, B.H.3
  • 3
    • 0033152176 scopus 로고    scopus 로고
    • Dipyridamole-mediated reversal of multidrug resistance in MRP over- expressing human lung carcinoma cells in vitro
    • DOI 10.1016/S0959-8049(99)00038-6, PII S0959804999000386
    • Curtin NJ, Turner DP. (1999). Dipyridamole-mediated reversal of multidrug resistance in MRP over-expressing human lung carcinoma cells in vitro. Eur J Cancer 35:1020-1026. (Pubitemid 29277141)
    • (1999) European Journal of Cancer , vol.35 , Issue.6 , pp. 1020-1026
    • Curtin, N.J.1    Turner, D.P.2
  • 4
    • 33751102419 scopus 로고    scopus 로고
    • Comparison of the activities of the truncated halichondrin B analog NSC 707389 (E7389) with those of the parent compound and a proposed binding site on tubulin
    • DOI 10.1124/mol.106.026641
    • Dabydeen DA, Burnett JC, Bai R, Verdier-Pinard P, Hickford SJ, Pettit GR, Blunt JW, Munro MH, Gussio R, Hamel E. (2006). Comparison of the activities of the truncated halichondrin B analog NSC 707389 (E7389) with those of the parent compound and a proposed binding site on tubulin. Mol Pharmacol 70:1866-1875. (Pubitemid 44771902)
    • (2006) Molecular Pharmacology , vol.70 , Issue.6 , pp. 1866-1875
    • Dabydeen, D.A.1    Burnett, J.C.2    Bai, R.3    Verdier-Pinard, P.4    Hickford, S.J.H.5    Pettit, G.R.6    Blunt, J.W.7    Munro, M.H.G.8    Gussio, R.9    Hamel, E.10
  • 6
    • 0032823160 scopus 로고    scopus 로고
    • Intestinal secretion of intravenous talinolol is inhibited by luminal R- verapamil
    • DOI 10.1016/S0009-9236(99)70031-7
    • Gramatté T, Oertel R. (1999). Intestinal secretion of intravenous talinolol is inhibited by luminal R-verapamil. Clin Pharmacol Ther 66:239-245. (Pubitemid 29451755)
    • (1999) Clinical Pharmacology and Therapeutics , vol.66 , Issue.3 , pp. 239-245
    • Gramatte, T.1    Oertel, R.2
  • 7
    • 24644518573 scopus 로고    scopus 로고
    • Etoposide, vincristine, and cyclosporin a with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: A pediatric oncology group phase I study
    • DOI 10.1002/pbc.20382
    • Greenberg ML, Fisher PG, Freeman C, Korones DN, Bernstein M, Friedman H, Blaney S, Hershon L, Zhou T, Chen Z, Kretschmar C. (2005). Etoposide, vincristine, and cyclosporin A with standarddose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: A pediatric oncology group phase I study. Pediatr Blood Cancer 45:644-648. (Pubitemid 41282815)
    • (2005) Pediatric Blood and Cancer , vol.45 , Issue.5 , pp. 644-648
    • Greenberg, M.L.1    Fisher, P.G.2    Freeman, C.3    Korones, D.N.4    Bernstein, M.5    Friedman, H.6    Blaney, S.7    Hershon, L.8    Zhou, T.9    Chen, Z.10    Kretschmar, C.11
  • 9
    • 33847420462 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of alfentanil in P-glycoprotein- competent and P-glycoprotein-deficient mice: P-glycoprotein efflux alters alfentanil brain disposition and antinociception
    • DOI 10.1124/dmd.106.011445
    • Kalvass JC, Olson ER, Pollack GM. (2007). Pharmacokinetics and pharmacodynamics of alfentanil in P-glycoprotein-competent and P-glycoprotein-deficient mice: P-glycoprotein efflux alters alfentanil brain disposition and antinociception. Drug Metab Dispos 35:455-459. (Pubitemid 46333909)
    • (2007) Drug Metabolism and Disposition , vol.35 , Issue.3 , pp. 455-459
    • Kalvass, J.C.1    Olson, E.R.2    Pollack, G.M.3
  • 11
    • 4143052665 scopus 로고    scopus 로고
    • Induction of morphological and biochemical apoptosis following prolonged mitotic blockage by halichondrin B macrocyclic ketone analog E7389
    • DOI 10.1158/0008-5472.CAN-04-1169
    • Kuznetsov G, Towle MJ, Cheng H, Kawamura T, TenDyke K, Liu D, Kishi Y, Yu MJ, Littlefield BA. (2004). Induction of morphological and biochemical apoptosis following prolonged mitotic blockage by halichondrin B macrocyclic ketone analog E7389. Cancer Res 64:5760-5766. (Pubitemid 39095575)
    • (2004) Cancer Research , vol.64 , Issue.16 , pp. 5760-5766
    • Kuznetsov, G.1    Towle, M.J.2    Cheng, H.3    Kawamura, T.4    TenDyke, K.5    Liu, D.6    Kishi, Y.7    Yu, M.J.8    Littlefield, B.A.9
  • 13
    • 34250331903 scopus 로고    scopus 로고
    • Transporter-mediated drug interactions: Clinical implications and in vitro assessment
    • DOI 10.1517/17425255.3.1.81
    • Lin JH. (2007). Transporter-mediated drug interactions: Clinical implications and in vitro assessment. Expert Opin Drug Metab Toxicol 3:81-92. (Pubitemid 47307456)
    • (2007) Expert Opinion on Drug Metabolism and Toxicology , vol.3 , Issue.1 , pp. 81-92
    • Lin, J.H.1
  • 14
    • 0029860174 scopus 로고    scopus 로고
    • Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdrla P-glycoprotein
    • Mayer U, Wagenaar E, Beijnen JH, Smit JW, Meijer DK, van Asperen J, Borst P, Schinkel AH. (1996). Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein. Br J Pharmacol 119:1038-1044. (Pubitemid 26366502)
    • (1996) British Journal of Pharmacology , vol.119 , Issue.5 , pp. 1038-1044
    • Mayer, U.1    Wagenaar, E.2    Beijnen, J.H.3    Smit, J.W.4    Meijer, D.K.F.5    Van Asperen, J.6    Borst, P.7    Schinkel, A.H.8
  • 15
    • 0031936939 scopus 로고    scopus 로고
    • Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin
    • Mechetner E, Kyshtoobayeva A, Zonis S, Kim H, Stroup R, Garcia R, Parker RJ, Fruehauf JP. (1998). Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to Taxol and doxorubicin. Clin Cancer Res 4:389-398. (Pubitemid 28122754)
    • (1998) Clinical Cancer Research , vol.4 , Issue.2 , pp. 389-398
    • Mechetner, E.1    Kyshtoobayeva, A.2    Zonis, S.3    Kim, H.4    Stroup, R.5    Garcia, R.6    Parker, R.J.7    Fruehauf, J.P.8
  • 16
    • 78650054235 scopus 로고    scopus 로고
    • Advances in therapy: Eribulin improves survival for metastatic breast cancer
    • Morris PG. (2010). Advances in therapy: Eribulin improves survival for metastatic breast cancer. Anticancer Drugs 21:885-889.
    • (2010) Anticancer Drugs , vol.21 , pp. 885-889
    • Morris, P.G.1
  • 18
    • 33745574979 scopus 로고    scopus 로고
    • Drug interactions in cancer therapy
    • DOI 10.1038/nrc1887, PII N1887
    • Scripture CD, Figg WD. (2006). Drug interactions in cancer therapy. Nat Rev Cancer 6:546-558. (Pubitemid 43980543)
    • (2006) Nature Reviews Cancer , vol.6 , Issue.7 , pp. 546-558
    • Scripture, C.D.1    Figg, W.D.2
  • 25
    • 0030963724 scopus 로고    scopus 로고
    • Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism
    • DOI 10.1006/taap.1997.8225
    • Umbenhauer DR, Lankas GR, Pippert TR, Wise LD, Cartwright ME, Hall SJ, Beare CM. (1997). Identification of a P-glycoproteindeficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism. Toxicol Appl Pharmacol 146: 88-94. (Pubitemid 27406400)
    • (1997) Toxicology and Applied Pharmacology , vol.146 , Issue.1 , pp. 88-94
    • Umbenhauer, D.R.1    Lankas, G.R.2    Pippert, T.R.3    Wise, L.D.4    Cartwright, M.E.5    Hall, S.J.6    Beare, C.M.7
  • 26
    • 0031941789 scopus 로고    scopus 로고
    • Taxol transport by human intestinal epithelial Caco-2 cells
    • Walle UK, Walle T. (1998). Taxol transport by human intestinal epithelial Caco-2 cells. Drug Metab Dispos 26:343-346. (Pubitemid 28201244)
    • (1998) Drug Metabolism and Disposition , vol.26 , Issue.4 , pp. 343-346
    • Walle, U.K.1    Walle, T.2
  • 27
    • 47549112107 scopus 로고    scopus 로고
    • Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4
    • Zhang ZY, King BM, Pelletier RD, Wong YN. (2008a). Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4. Cancer Chemother Pharmacol 62:707-716.
    • (2008) Cancer Chemother Pharmacol , vol.62 , pp. 707-716
    • Zhang, Z.Y.1    King, B.M.2    Pelletier, R.D.3    Wong, Y.N.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.